The aim of the collaboration is to advance the use of Cellectar's phospholipid drug conjugate platform for targeted delivery of a selection of Pierre Fabre's cytotoxics. / read more /
Recipharm has signed an agreement with Sweddish pharmaceutical company LIDDS for the production scale up and manufacture of LIDDS' Liproca depot for the treatment of prostate cancer. / read more /
Microorganism lethality requirements for process validation must always be balanced with the need to protect product integrity and patient safety. / read more /
Analytical methods and functional assays are used to compare molecules and relate characteristics to quality attributes for determining biosimilarity. / read more /
All openings and potential breaches for air penetration must be considered when designing a cleanroom so that the HVAC system can maintain the desired negative or positive pressure. / read more /
Finalizing GMP requirements and quality standards for the development, manufacture, and clinical testing of ATMPs in the EU is proving to be a complex task. / read more /
Quality by design, in-vitro release testing, and modern analytical methods are improving understanding and control of these complex formulations. / read more /
APTAR PHARMA PRESENTS A STEP CHANGE IN THE PERFORMANCE OF DF30Plus FOR pMDIs INCORPORATING COC Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products, presents its latest innovation, DF30Plus with COCe. / Read more /
Proper drug release of high-dose hydrophilic drugs is a challenge for formulators since both the initial drug burst release, as well as the consequent sustained release, need to be controlled. Excipients can provide an answer to drug release challenges when their hydrophobic nature is coupled with thermal sintering. This approach intensifies the retardation of drug release by forming plastic matrices of high mechanical strength, which can withstand dose dumping and achieve controlled release. In this webcast, a formulation expert will discuss BASF's Kolliwax grades and their suitability for thermal sintering; describe how high-dose hydrophilic actives were selected to demonstrate the efficacy of thermal sintering (60-65% w/w) using Kolliwax grades; and present processing parameters to enable customers to reproduce controlled drug release of hydrophilic drugs using thermal sintering. Sponsored by BASF
On Demand
Risk Management Plans have become a cornerstone in the pharmacovigilance of new drugs. It was introduced to support a proactive approach in gaining knowledge on safety concerns through early planning of pharmacovigilance activities. In this webinar, EtQ and HighPoint Solutions will cover the regulations around the EMA's Risk Management Plan and also the FDA's Risk Evaluation and Mitigation Strategy. Sponsored by EtQ
A compilation of informative, useful articles designed to help you meet the challenges of process analytical technology, be more efficient in testing, reduce over-processing, enhance consistency, and minimize rejects. / Click here /
Pharmaceutical Technology's Drug Development Application Handbook is a compilation of technical articles from the magazine's archives and application notes, technical information, and educational materials from the handbook's sponsors.
